《亚洲股市》日经及中韩港股跌0.8%-1.5% 恒指跑输失二万五 惟星马澳股逆弹
美股昨晚个别发展,美国经济数据继续表现参差,加上商品价格下挫,其中纽约期油跌2.7%六连跌,逾半蓝筹向下,金融、工业及油股沽压较大,尤其是Nike、运通、Walgreens、陶氏、雪佛龙、卡特彼勒及波音挫1.9%-3.1%,但医保护理股及受惠债息降的蓝筹科技股普遍反弹,尤其是季绩胜预期思科涨3.8%,宝洁、微软及联合健康升1.2%-2.5%,支持道指由曾跌270点,收窄至仅跌66点三连吐;Tesla回吐逾2%,但奈飞升逾4%,费城半导体指数回升0.8%,支持纳指及标普反覆回升0.1%,分别结束三连跌及两连跌。不过,欧洲主要股市全面追跌1.2%-2.4%,CAC跑输,但前天升逾1%跑赢西班牙仅吐0.8%。
美股期货好淡争持,其中道指期货报34,797,反覆续跌21点,但纳指期货报14,935,逆市续升7点。亚太区股市早段窄幅个别发展。美汇指数四连升报93.55创九个月高,其中美元兑日圆今早於亚洲微升不足0.1%报109.79,但日本疫情严峻,日本连续10个月呈通缩,日经继昨天回落逾1%後,今早仍反覆受压,最高见27,316无以为继,现报27,051,续跌230点或0.8%。
韩股继昨天急挫1.9%後,今早续跌1.1%报3,062。台湾加权指数继昨天低收急挫2.7%创近三个月低後,今早续跌0.2%报16,339。
受惠央行意外未有加息的新西兰50指数继昨天逆市高收续涨1.9%後,今早高见12,976乏力,现报12,930,倒跌0.2%。
港股继昨天在新经济股等主导曾急挫至25,183喘定,收25,316,仅挫550点或2.1%,今早在药明生物(02269.HK)、中绩多赚2.2倍中期股息年增50%的中海油(00883.HK)、昨天急挫美团(03690.HK)/阿里巴巴(09988.HK)低开1.3%-2.5%,抵消中绩多赚21%历来首派中期息12分兼拟分拆智网科技A股上市的联通(00762.HK)高开5.6%、建行(00939.HK)/申洲(02313.HK)/碧桂园(02007.HK)/石药(01093.HK)高开逾1%-3%,恒指低开75点或0.3%,跌幅扩至384点或1.5%,报24,931。
沪指继昨天回吐0.6%後,今早低开近0.7%报3,442,现报3,428,续跌1.1%;深成继昨天反覆续升0.2%後,今早低开0.8%,现报14,330,回吐1.1%。
相反,当地疫情反弹的澳洲200由纪录高位四连吐後,今早微升0.2%报7,477。新加坡海峡时报指数扭转昨天跌1.4%势,报3,107,回升0.7%。吉隆坡综合指数回升0.3%报1,519。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.